Deverab

Deverab offers a comprehensive treatment approach for GERD, acidity, and related gastric disorders, combining the potency of Rabeprazole (a superior PPI) with proven prokinetic agents for enhanced patient outcomes.

Available Combinations:

• Deverab-LS: Rabeprazole 20 mg + Levosulpiride SR 75 mg (Capsules)
• Deverab-DM: Rabeprazole 20 mg + Domperidone 10 mg (Tablets)
• Deverab-DSR: Rabeprazole 20 mg + Domperidone SR 30 mg (Capsules)
• Domperidone SR – Prevents nausea, vomiting, and bloating while improving gastric motility.

Why Deverab?

• Potency of Rabeprazole: Strong acid suppression with effective oesophagitis healing and long-term maintenance therapy.
• Enhanced Gastric Motility: Levosulpiride & Domperidone improve gastric emptying, relieve bloating, nausea, and dyspepsia.
• Clinically Proven Safety: Effective for both short-term relief and long-term therapy with better tolerability.
• Combination Synergy: Provides dual benefit—acid suppression plus symptom control (regurgitation, nausea, indigestion).

Therapeutic Benefits

• Deverab is effective in the management of: GERD associated with stress, Functional dyspepsia, Irritable bowel syndrome, Peptic oesophagitis, Peptic ulceration & related GI disorders, Reflux oesophagitis, Indigestion & bloating, Anxiety-related GI disorders, Essential cephalgia (GERD-linked headaches).

Why Deverab?

• Strong & sustained acid suppression
• Faster healing of oesophagitis & ulcers
• Relieves nausea, bloating & upper GI symptoms
• Effective in both acute & maintenance therapy
• Superior patient compliance with multiple dosage options